Physician profile
Scott E Sanderson
NPI 1093755282
$350.95
in general payments reported to CMS, 2019-2025
11 companies · $17.05 in 2025
The $17.05 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $48.76 · 2020: $61.82 · 2022: $156 · 2023: $66.91 · 2025: $17.05.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $83.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $83.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Depuy Synthes Sales INC. | $126.33 | 2022 | |
| Novartis Pharmaceuticals Corporation | $68.23 | 2022-2023 | |
| Glaukos Corporation | $25.18 | 2020 | |
| Allergan, INC. | $21.62 | 2019 | |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Johnson & Johnson Surgical Vision, INC. | $17.05 | 2025 | Tecnis Simplicity, Veritas Vision System |
| Dompe US, INC. | $15.88 | 2019 | |
| Coopervision INC. | $14.50 | 2023 | Myday Contact Lens |
| Rxsight INC | $14.26 | 2023 | Rxsight Injector Cartridge, Rxsight Contact Lens, Rxsight Light Delivery Device (Ldd) |
| Sun Pharmaceutical Industries INC. | $11.26 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Sanderson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.